Variables | Total n (%) | Died n (%) | Censored n (%) |
---|---|---|---|
Survival time (years)a | 9.9 (0.0, 9.9) | – | – |
Survival time (years)b | 5.4 (6.2) | – | – |
Age at diagnosis (years)c | 50.4 (11.2) | – | – |
Age at diagnosis | |||
> 50 years | 248 (45.2) | 107 (42.0) | 141 (48.0) |
≤ 50 years | 301 (54.8) | 150 (58.0) | 151 (52.0) |
Ethnicity: | |||
Malay | 471 (85.8) | 240 (93.0) | 231 (79.0) |
Chinese | 65 (11.8) | 15 (6.0) | 50 (17.0) |
Indian | 5 (1.0) | 1 (0.0) | 4 (1.0) |
Siam | 6 (1.1) | 0 (0.0) | 6 (2.0) |
Others | 2 (0.4) | 1 (0.0) | 1 (0.0) |
Stages: | |||
Stage І | 163 (29.7) | 53 (21.0) | 110 (38.0) |
Stage ІІ | 161 (29.3) | 33 (13.0) | 128 (44.0) |
Stage ІІІ | 90 (16.4) | 53 (21.0) | 37 (13.0) |
Stage IV | 135 (24.6) | 118 (46.0) | 17 (6.0) |
Morphology: | |||
Carcinoma, NOS | 2 (0.4) | 2 (0.8) | 0 (0.0) |
Carcinoma undifferentiated, NOS | 1 (0.2) | 0 (0.0) | 1 (0.3) |
Papillary carcinoma, NOS | 17 (3.1) | 9 (3.5) | 8 (2.7) |
Squamous cell carcinoma, NOS | 7 (1.3) | 4 (1.6) | 3 (1.0) |
Adenocarcinoma, NOS | 68 (12.4) | 38 (14.8) | 30 (10.3) |
Adenoid cystic carcinoma | 1 (0.2) | 0 (0.0) | 1 (0.3) |
Infiltrating ductal carcinoma, NOS | 448 (81.6) | 202 (78.6) | 246 (84.3) |
Medullary carcinoma, NOS | 1 (0.2) | 0 (0.0) | 1 (0.3) |
Lobular carcinoma, NOS | 2 (0.4) | 1 (0.4) | 1 (0.3) |
Infiltrating ductal and lobular carcinoma | 1 (0.2) | 1 (0.4) | 0 (0.0) |
Sarcoma, NOS | 1 (0.2) | 0 (0.0) | 1 (0.3) |
Surgery | |||
No | 275 (50.0) | 154 (60.0) | 121 (41.0) |
Yes | 274 (49.9) | 103 (40.0) | 171 (59.0) |
Radiotherapy | |||
No | 444 (80.9) | 211 (82.0) | 233 (80.0) |
Yes | 105 (19.1) | 46 (18.0) | 59 (20.0) |
Chemotherapy | |||
No | 386 (70.3) | 170 (66.0) | 216 (74.0) |
Yes | 163 (29.7) | 87 (34.0) | 76 (26.0) |